Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
ConditionUterine Neoplasms
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity Hospital Tuebingen
About this trial
Evaluation of clinical, therapeutic and prognostic relevance of new experimental results as well as optimization of therapeutic models and development of a new algorithm for therapeutic plan and therapy in patients with uterine neoplasm
Eligibility criteria
Qualifiers
Confirmed uterine malignancy ( cervical cancer, endometrial cancer, sarcoma)
If operable: surgical primary therapy: laparoscopic/robot-assisted or open radical gyneco-oncological surgery
Written consent
Willingness and ability to participate in all study-specific procedures
Disqualifiers
Severe and acute general disease in the last 4 weeks
Acute or chronic psychiatric disorders
Other factors questioning study participation (e.g. acute psychosocial stress, insufficient understanding of nature and consequences of the study, inadequate skills of the German language)
Trial design
Treatments tested in this trial
- uterine neoplasms
Treatment groups
580 Participants
are divided into 1 treatment groupSponsors and collaborators
University Hospital Tuebingen
Lead sponsor
University Hospital Heidelberg
Collaborator
University of Homburg
Collaborator
University Hospital Freiburg
Collaborator
Source ClinicalTrials.gov